ETHOTOIN

ETHOTOIN Basic information
Product Name:ETHOTOIN
Synonyms:1-Ethyl-2,5-dioxo-4-phenylimidazolidine;2,4-Imidazolidinedione, 3-ethyl-5-phenyl-;3-Ethyl-5-phenyl-2,4-imidazolidinedione;3-ethyl-5-phenyl-hydantoi;3-Ethyl-5-Phenylhydantoin;3-Ethyl-5-phenylimidazolidin-2,4-dione;AC-695;Accenon
CAS:86-35-1
MF:C11H12N2O2
MW:204.23
EINECS:201-665-1
Product Categories:
Mol File:86-35-1.mol
ETHOTOIN Structure
ETHOTOIN Chemical Properties
Melting point 94°C
Boiling point 342.72°C (rough estimate)
density 1.1754 (rough estimate)
refractive index 1.5200 (estimate)
storage temp. Refrigerator
solubility Dichloromethane (Slightly), DMSO (Slightly), Methanol (Slightly)
form Solid
pka8.01±0.70(Predicted)
color White to Off-White
Safety Information
Risk Statements 22
HS Code 2933210000
Hazardous Substances Data86-35-1(Hazardous Substances Data)
MSDS Information
ETHOTOIN Usage And Synthesis
OriginatorPeganone,Abbott,US,1957
UsesEthotoin is less active and less toxic than phenytoin. It is used for the same indications as is phenytoin, i.e. for control of major and complex epileptic attacks.
UsesEthotoin is a hydantoin based anticonvulsant drug used in the treatment of epilepsy.
DefinitionChEBI: An imidazolidine-2,4-dione that is hydantoin substituted by ethyl and phenyl at positions 3 and 5, respectively. An antiepileptic, it is less toxic than phenytoin but also less effective.
Manufacturing ProcessBenzaldehyde cyanohydrin is reacted with urea to displace the hydroxyl group of the cyanohydrin. That intermediate is treated with HCl to convert the urea nitrogen to a nitrile. The resultant imine is hydrolyzed to the phenylhydantoin. Alkylation with ethyl iodide gives ethotoin, as described by A. Pinner in Chem. Ber. 21, 2325 (1888).
Brand namePeganone (Ovation.
Therapeutic FunctionAnticonvulsant
SynthesisEthotoin, 3-ethyl-5-phenylimidazolidine-2,4-dione (9.1.5), is synthesized in basically the same manner as described above, which in this case involves the reaction of benzaldehyde oxynitrile (9.1.2), with urea or ammonium hydrocarbonate, which forms the intermediate urea derivative (9.1.3) which on acidic conditions (9.1.3) cyclizes to 5-phenylhydantoin (9.1.4). Alkylation of this product using ethyliodide leads to the formation of ethotoin (9.1.5) [3,4].

Synthesis_86-35-1

MetabolismEthotoin differs from phenytoin in that one phenyl substituent at position 5 has been replaced by hydrogen, and the N-H at position 3 is replaced by an ethyl group. It may be indicated for treatment of tonic-clonic and complex partial (psychomotor) seizures. Because it is considered to be less toxic but also less effective and more sedating than phenytoin, ethotoin usually is reserved for use as an add-on drug. Ethotoin does not share phenytoin's profile of antiarrhythmic action. The metabolism of ethotoin, like phenytoin, is saturable and nonlinear. Its administration is contraindicated in patients with hepatic abnormalities and hematologic disorders.
Purification MethodsIt is an anticonvulsant and is used in epilepsy. [Dudley et al. J Heterocycl Chem 10 173 1973, Pinner Chem Ber 21 2320 1888, Beilstein 25 III/IV 963, 27 II 860.]
ETHOTOIN Preparation Products And Raw materials
Raw materialsIodoethane-->Mandelonitrile-->Hydrochloric acid
5,5-DIPHENYLHYDANTOIN-3-BUTYRIC ACID ETHOTOIN [4-(4-FLUOROPHENYL)-4-METHYL-2,5-DIOXOIMIDAZOLIDIN-1-YL]ACETIC ACID Ropitoin Hydantoin (4-METHYL-2,5-DIOXO-4-PHENYL-IMIDAZOLIDIN-1-YL)-ACETIC ACID (4-[4-(2-AMINO-2-OXOETHOXY)PHENYL]-4-METHYL-2,5-DIOXOIMIDAZOLIDIN-1-YL)ACETIC ACID (2,5-DIOXO-3',4'-DIHYDRO-1H,2'H-SPIRO[IMIDAZOLIDINE-4,1'-NAPHTHALEN]-1-YL)ACETIC ACID (4-ETHYL-2,5-DIOXO-4-PHENYLIMIDAZOLIDIN-1-YL)ACETIC ACID (+/-)-N-3-Benzylnirvanol (2,5-DIOXO-2',3'-DIHYDRO-1H-SPIRO[IMIDAZOLIDINE-4,1'-INDEN]-1-YL)ACETIC ACID [4-METHYL-4-(2-NAPHTHYL)-2,5-DIOXOIMIDAZOLIDIN-1-YL]ACETIC ACID 1-(4-(2-Hydroxyethyl)-1-piperazine-2-propanolo)-3-ethyl-5,5-diphenylhy dantoin 2HCl hydrate (2',5'-DIOXO-2,3-DIHYDRO-1'H-SPIRO[CHROMENE-4,4'-IMIDAZOLIDIN]-1'-YL)ACETIC ACID 5-Phenylhydantoin [4-METHYL-4-(4-METHYLPHENYL)-2,5-DIOXOIMIDAZOLIDIN-1-YL]ACETIC ACID 2,4-Imidazolidinedione, 5,5-diphenyl-3-ethyl-1-(2-hydroxy-3-(1-piperid inyl)propyl)-, monohydrochloride [4-(4-METHOXY-PHENYL)-4-METHYL-2,5-DIOXO-IMIDAZOLIDIN-1-YL]-ACETIC ACID

Email:[email protected] [email protected]
Copyright © 2024 Mywellwork.com All rights reserved.